Polymorphism of the follistatin gene in polycystic ovary syndrome
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Follistatin has been reported as a candidate gene for polycystic ovary syndrome (PCOS) from linkage and association studies. Acting to regulate the development of ovarian follicles and as an antagonist to aromatase activity, alterations in follistatin function or expression may result in key features of PCOS such as reduced serum FSH, impaired ovarian follicle development and augmented ovarian androgen production. We investigated polymorphisms in the FST gene to determine if genetic variation is associated with susceptibility to PCOS or key phenotypic features of PCOS patients in a case-control association study. One hundred and seventy-three PCOS patients of Caucasian descent (mean age 30.0 +/- 4.8 years), conforming to the NIH diagnostic criteria, were recruited from a clinical practice database and 107 normal ovulating women (mean age 38.8 +/- 13.4 years) were recruited from the general community as control subjects. Morphometric data, biochemistry and genomic DNA were collected from study subjects and genotyping was performed on seven Single nucleotide polymorphisms (SNPs) in the FST gene region. Allele frequencies of the SNPs were rs1423560 G/C (0.99/0.01), rs3797297 C/A (0.80/0.20), rs11745088 C/G (0.98/0.02), rs3203788 A/T (0.98/0.02) and rs1062809 G/C (1.00/-), rs1127760 A/T (0.98/0.02) and rs1127761 A/T (0.98/0.02), and these were not significantly different between the PCOS and control groups (P < 0.05). Statistical analysis revealed significant associations between the SNP rs3797297 and sex hormone-binding globulin (P = 0.04) and free androgen index (FAI) (P < 0.01). We conclude that FST is not a susceptibility locus for PCOS; however, the SNP rs3797297 from FST gene was associated with androgenic markers for PCOS and may be of importance in the hyperandrogenaemia of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Pedigree disequilibrium tests for multilocus haplotypes.
Dudbridge, F. (2003) · Genetic Epidemiology · doi:10.1002/gepi.10252 · Cited by 1,135
Molecular progress in infertility: polycystic ovary syndrome
Legro, R. S., & Strauss, J. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03275-2 · Cited by 180 · cited 1×
“The diversity of PCOS within families and between PCOS patients suggests that inheritance of the disorder could be both multifactorial and polygenic (Legro and Strauss, 2002).”
Acién, P., Quereda, F., Matallı́n, P., Villarroya, E., López-Fernández, J. A., Acién, M., Mauri, M., & Alfayate, R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00184-3 · Cited by 170 · cited 1×
“Multiple genetic pathways have been implicated in the pathogenesis of PCOS including steroid hormone metabolism, gonadotropin action, obesity and energy regulation and insulin action (Dunaif et al., 1988; Acien et al., 1999; Moran et al., 2003; Moran and Norman 2004).”
Eldar-Geva, T., Spitz, I. M., Groome, N. P., Margalioth, E. J., & Homburg, R. (2001) · Human Reproduction · doi:10.1093/humrep/16.12.2552 · Cited by 94 · cited 4×
“The discovery that follistatin levels are significantly higher in PCOS patients, independent of obesity (Eldar-Geva et al., 2001), suggests that alteration in follistatin function may contribute to the PCOS phenotype.”
Influential
Cited by
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome
Wang, J., Wu, D., Guo, H., & Li, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116940 · Cited by 322
Xu, N., Kwon, S., Abbott, D. H., Geller, D. H., Dumesic, D. A., Azziz, R., Guo, X., & Goodarzi, M. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027286 · Cited by 155
“Significant differentially methylated genes identified from infant and adult data are involved in TGF-b signaling, a pathway currently implicated in the pathogenesis of PCOS in women by genetic epidemiologic evidence [24,25,26,27], supporting the potential contributory role of epigenomic perturbation in the etiology o…”
BackgroundAssociation between vaspin rs2236242 gene polymorphism and polycystic ovary syndrome risk
Kohan, L., Zarei, A., Fallahi, S., & Tabiee, O. (2014) · Gene · doi:10.1016/j.gene.2014.01.078 · Cited by 23
Metadata
- Authors
- Jones, M. R., Wilson, S. G., Mullin, B. H., Mead, R., Watts, G. F., & Stuckey, B. G. A.
- Venue
- MHR: Basic science of reproductive medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-06
- Volume
- 13
- Issue
- 4
- Pages
- 237-241
- ISSN
- 1360-9947 (ISSN-L)
- 1460-2407
- OpenAlex
- W2106213718
- Cited by
- 41
- References
- 5
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polymorphism of the follistatin gene in polycystic ovary syndrome. https://app.cochat.ai/papers/10.1093/molehr/gal120
- The paper
- Jones, M. R., Wilson, S. G., Mullin, B. H., Mead, R., Watts, G. F., & Stuckey, B. G. A. (2007). Polymorphism of the follistatin gene in polycystic ovary syndrome. MHR: Basic science of reproductive medicine. https://doi.org/10.1093/molehr/gal120
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.